Cargando…
Small interfering RNA targeting N-cadherin regulates cell proliferation and migration in enzalutamide-resistant prostate cancer
Enzalutamide is one of the options for treating patients with castration-resistant or metastatic prostate cancer. However, a substantial proportion of patients become resistant to enzalutamide after a period of treatment. Cells in these tumors typically exhibit increased proliferative and migratory...
Autores principales: | Lu, Cheng-Hsin, Wu, Chun-Hsien, Hsieh, Pei-Fang, Wu, Chen-Yu, Kuo, Wade Wei-Ting, Ou, Chien-Hui, Lin, Victor Chia Hsiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805176/ https://www.ncbi.nlm.nih.gov/pubmed/35126732 http://dx.doi.org/10.3892/ol.2022.13210 |
Ejemplares similares
-
High Tumor Burden Predicts Poor Response to Enzalutamide in Metastatic Castration-Resistant Prostate Cancer Patients
por: Hsieh, Yu-Ting, et al.
Publicado: (2021) -
Interfering with pak4 Protein Expression Affects Osteosarcoma Cell Proliferation and Migration
por: Fu, Yuxin, et al.
Publicado: (2021) -
Molecular determinants for enzalutamide-induced transcription in prostate cancer
por: Yuan, Fuwen, et al.
Publicado: (2019) -
YAP1 overexpression contributes to the development of enzalutamide resistance by induction of cancer stemness and lipid metabolism in prostate cancer
por: Lee, Hsiu-Chi, et al.
Publicado: (2021) -
Aspalathus linearis suppresses cell survival and proliferation of enzalutamide-resistant prostate cancer cells via inhibition of c-Myc and stability of androgen receptor
por: Wang, Bi-Juan, et al.
Publicado: (2022)